General compendium of HDAC inhibitors with deep emphasis on toxicity issues of synthetic HDAC inhibitors
Various groups of natural HDAC inhibitors, their representatives and premier sources
Cyclic tetrapeptides of natural origin and their importance as cancer chemotherapeutic agents
Hydroxamates and depsipeptides from natural sources and their promising role in cancer therapy
Natural Flavonoids, their HDAC inhibitory tendency and marvellous anticancer activity
Non-flavonoid natural HDAC inhibitors and their pleasing cytotoxic effects towards cancer models
Combined therapy involving natural flavonoids with other anticancer molecules for synergistic and additive benefits against cancer models
Non-flavonoid HDAC inhibitors and conventional drugs in collaborative mode against aggressive malignancies
Nanotechnology based delivery of natural HDAC inhibitors for greater therapeutic efficacy over traditional combinatorial therapy
